Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stony Brook University medical researcher developing new medication to prevent colon cancer

20.10.2004


A Stony Brook University researcher is testing a new form of aspirin--one that is much more potent than its commercially available counterpart, but with almost none of the side effects--to determine whether it can be used to prevent colon cancer in patients who are prone to the disease.



The study of the new medication--called nitric oxide-donating aspirin, or nitroaspirin--is supported by a $3.2 million grant from the National Cancer Institute. Basil Rigas, M.D., Professor of Medicine and Chief of the Division of Cancer Prevention at Stony Brook’s School of Medicine, will report the findings of his trials on laboratory animals at the third annual International Conference on Frontiers in Cancer Prevention Research today in Seattle. The conference is sponsored by the American Association for Cancer Research.

"Studies in cell culture and animals have shown that this new aspirin is hundreds to thousands of times more potent than traditional aspirin in inhibiting the growth of colon cancer cells and quite effective in preventing the development of colon cancer in laboratory animals," said Dr. Rigas, who will begin human trials of nitroaspirin by the end of this year.


While traditional aspirin has been shown to be effective in clinical trials in preventing certain cancers, it also is associated with significant side effects, including gastrointestinal bleeding, kidney damage, and allergic reactions ranging from mild to fatal. In addition, traditional aspirin is typically effective in preventing cancer in only about 50 per cent of those who take it.

Colon cancer can take many years to develop, but it is frequently not diagnosed in its earliest stages because cancerous lesions in the colon grown slowly and often without symptoms. More than 148,000 new cases of colon cancer are diagnosed in the U.S. each year and more than 56,000 Americans die of the diseases annually, according to the American Cancer Society.

In order to arrive at a more accurate diagnosis in less time, Dr. Rigas and his colleagues are using an advanced imaging technique called magnifying endoscopy to examine the growth of the earliest recognizable lesions, known as aberrant crypt foci, or ACF. The imaging technique will be used to evaluate 240 patients they expect to enroll over the next three years.

Dr. Rigas’ work focuses on the pharmacological prevention of cancers of the colon and the pancreas. His group has made key contributions to our understanding of how aspirin and aspirin-like drugs prevent colon and other cancers. He is now developing the highly promising nitroaspirin for the prevention of colon and pancreatic cancer, being supported by five NIH grants. He also pioneered the application of infrared spectroscopy to biology with emphasis on cancer, and holds several relevant patents. He is the author of over 100 peer-reviewed publications and has co-authored a textbook of Gastroenterology, which was translated into several foreign languages.

Warren Froelich | EurekAlert!
Further information:
http://www.aacr.org

More articles from Health and Medicine:

nachricht Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Predicting unpredictability: Information theory offers new way to read ice cores

07.12.2016 | Earth Sciences

Sea ice hit record lows in November

07.12.2016 | Earth Sciences

New material could lead to erasable and rewriteable optical chips

07.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>